• Mashup Score: 8
    Unexpected Closure | NEJM - 2 year(s) ago

    Perspective from The New England Journal of Medicine — Unexpected Closure

    Source: New England Journal of Medicine
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of Tuhina_Neogi
      Tuhina_Neogi

      A *must-read* for #rheumatologists. Wonderfully written piece by @SaraKTedeschi, and wonderful that @petercgrayson played an important role -- two wonderful people I'm so fortunate to know and have the pleasure of working with. Unexpected Closure | NEJM https://t.co/5JBmY4iB9W

  • Mashup Score: 0
    Podcast - 2 year(s) ago

    Listen to ACR on Air, the official podcast of the American College of Rheumatology, for information on rheumatic disease research, solutions for practice management issues, legislative policies impacting patient care, and more.

    Source: www.rheumatology.org
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of hausmannMD
      hausmannMD

      What is #Kawasaki Disease and how should we treat it? What do #rheumatologists need to know? Learn more about the recent @ACRheum/@VasculitisFound Guidelines from the study's lead author Dr. Gorelik in the latest podcast episode from https://t.co/pINVoujoXK. https://t.co/OCuCyQmesy

  • Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Source: lww.com
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of JRheumatology
      JRheumatology

      94% #Rheumatologists recommend #Virtual Learning Collaborative for #TreatToTarget in #RheumatoidArthritis FREE TO READ THIS MONTH https://t.co/tTcEqzJvAO #rheumatology #RA #immunology #targetedtherapy #personalisedmedicine https://t.co/sfAVqDaLjV

  • Mashup Score: 0
    ‘Risk averse’ rheumatologists report declining JAK use, increased reliance on abatacept - 2 year(s) ago

    The safety signals for cardiovascular events and malignancy associated with Janus kinase inhibitors in rheumatoid arthritis have led to rheumatologists increasingly reaching for abatacept instead, according to data.The market analysis firm Spherix Global Insights surveyed 102 rheumatologists through the first quarter of 2022 and found that rheumatologists are increasingly opting for abatacept

    Source: www.healio.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GoHealio
      GoHealio

      The safety signals for cardiovascular events and malignancy associated with Janus kinase inhibitors in rheumatoid arthritis have led to #rheumatologists increasingly reaching for #abatacept instead https://t.co/MOfOmIcifL

    • Profile photo of HealioRheum
      HealioRheum

      The safety signals for cardiovascular events and malignancy associated with Janus kinase inhibitors in rheumatoid arthritis have led to #rheumatologists increasingly reaching for #abatacept instead https://t.co/CongJVtyck

  • Mashup Score: 0
    Intersection of ‘highly heterogenous’ COVID-19, IMIDs remains ‘poorly understood’ - 2 year(s) ago

    Scientific advancement has yielded slow but steady progress in the understanding of COVID-19, particularly in patients with immune-mediated conditions, a presenter said at the Basic and Clinical Immunology for the Busy Clinician symposium. “COVID-19 merits a serious place in the pantheon of pandemics,” Leonard Calabrese, DO, RJ Fasenmyer Chair of the Center for Clinical Immunology at

    Source: www.healio.com
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of HealioRheum
      HealioRheum

      The “intersection” of #COVID19 and #IMIDs “still remains poorly understood,” @LCalabreseDO told attendees at Basic and Clinical Immunology for the Busy Clinician. COVID's “highly heterogeneous” nature has made it an elusive target for #rheumatologists https://t.co/XnJwrsEmuB

  • Mashup Score: 2
    Much about post-acute COVID syndromes remains ‘poorly defined’ - 2 year(s) ago

    Despite a growing body of evidence documenting the existence of post-acute COVID-19 syndromes, there remain many more questions than answers, according to data presented at the Basic and Clinical Immunology for the Busy Clinician symposium. Leonard Calabrese, DO, RJ Fasenmyer chair of clinical immunology at the Cleveland Clinic, covered long COVID — also called

    Source: www.healio.com
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of HealioRheum
      HealioRheum

      When addressing #LongCovid #rheumatologists lack “a uniform definition, no specific criteria, serious reporting bias and no diagnostic biomarkers,” @LCalabreseDO told attendees at @ClevelandClinic 's Basic and Clinical Immunology for the Busy Clinician https://t.co/r54XaO4CHn

Load More